1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Yamato Holdings Co Ltd
  6. News
  7. Summary
    9064   JP3940000007

YAMATO HOLDINGS CO LTD

(9064)
  Report
Delayed Japan Exchange  -  05/23 02:00:00 am EDT
2317.00 JPY   +0.30%
05/03SLAMcore Limited announced that it has received $16 million in funding from a group of investors
CI
04/12CYCLOTECH AND YAMATO REVEAL INNOVATIVE CARGO EVTOL CONCEPT WITH CYCLOROTORS[PDF : 456.4kb]
PU
04/01Australian Shares Post Small Loss Amid Decline in Business Confidence
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sysmex and Yamato Transport Commence Dry Ice-Free Transportation ofReagents for Gene Testing in Consolidated Cargo at the Ultralow TemperatureRange of Minus 70 Degrees Celsius- Realizing an Eco-Friendly, Low-Cost, and Sustainable Pharmaceutical Product Cold Chain - [PDF:668.7KB]

12/23/2021 | 01:07am EDT

December 23, 2021

Yamato Transport Co., Ltd.

Sysmex Corporation

Sysmex and Yamato Transport Commence Dry Ice-Free Transportation of Reagents for Gene Testing in Consolidated Cargo at the Ultralow Temperature Range of Minus 70 Degrees Celsius

- Realizing an Eco-Friendly,Low-Cost, and Sustainable Pharmaceutical Product Cold Chain -

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and Yamato Transport Co., Ltd.

(HQ: Chuo-ku, Tokyo, Japan; President: Yutaka Nagao) announced today the commencement of dry ice-free1 transportation of reagents for gene testing in consolidated cargo at the ultralow temperature range of minus 70 degrees Celsius. This marks the first time this has been accomplished in the Japanese in vitro diagnostic products industry, with transportation commencing from Sysmex's office in Kobe to a testing organization in Kawasaki in December 2021.

This model is revolutionary because it is both eco-friendly and cost effective for long-distance transportation of pharmaceutical and other products at the ultralow temperature range of minus 70 degrees Celsius, which requires the most strict quality and temperature control, without using any dry ice. Previously, the use of dry ice was considered essential.

Going forward, the two companies will expand the list of products for transportation and the delivery service area to realize a sustainable cold chain for pharmaceutical products, thus providing quality and stable product supply to medical professionals.

Sysmex uses dedicated trucks and charter services to transport reagents for gene testing, which demands a high level of quality and temperature control, making it necessary to address transportation cost, flexibility in logistics, and efficiency. Furthermore, this mode of transport requires dry ice from CO2, which is a byproduct of other industrial processes such as oil refining, for cold storage throughout the transportation process. To reduce the environmental burden, stabilize procurement, and mitigate the risk of rising procurement costs, Sysmex has been seeking ways to improve.

To offer solutions to these challenges and achieve a stable supply of reagents for gene testing to medical professionals, in February 2021, Sysmex and Yamato Transport commenced GDP-compliant2 transportation of such reagents in consolidated cargo in an ultralow temperature range, while reducing the amount of dry ice used by around 50%.

In an effort to further reduce the environmental burden, Sysmex and Yamato Transport have conducted transportation trials in which refrigerants frozen in an ultralow-temperature freezer are used to substitute dry ice during transportation, to confirm cooling performance higher than when using dry ice. Following the trials' results, in December 2021, the two companies commenced dry ice-free transportation of reagents for gene testing in consolidated cargo at the ultralow temperature range of minus 70 degrees Celsius for the first time in the Japanese in vitro diagnostic products industry between Sysmex's office in Kobe and a testing institution in Kawasaki.

Going forward, the two companies will expand the list of products for transportation and the delivery service area in Japan by utilizing this model, which makes long-haul transportation of pharmaceutical and other products possible without dry ice. The two companies will also apply this model to international transportation services in an attempt to advance the cold chain by achieving quality and stable product supply.

Transportation Flow of Reagents for Gene Testing

  • No need to use gas-barrier bags and vacuum packaging at the time of shipment to prevent products from acidifying
    • Reduced environmental burden and workload and stabilized quality
  • Temperature during transportation is stabilized over a long time (Trials' results: minus 65 degrees Celsius or below, for about 48 hours)
    • Stabilized quality
  • No need to worry about dry ice adhering to products and unpacking staff becoming hypoxic at the time of delivery
     Reduced workload

Terminology

  • Using no dry ice
  • Good Distribution Practices: A basic scheme for assuring the quality of pharmaceuticals in the distributive process, from shipment from a manufacturing plant to delivery to medical institutions.

Reference

February 1, 2021 press release entitled "Sysmex and Yamato Logistics to Commence GDP-Compliant Transport of Reagents for Gene Testing at the Ultralow Temperature Range of Minus 70 Degrees Celsius or Below - Also Commencing Experiments for Ultralow Temperature Transport Without Using Dry Ice -"

https://www.yamato-hd.co.jp/english/assets/pdf/2021_01_news.pdf

[Press Contacts] Corporate Communication Department, Yamato Transport Co., Ltd. TEL: 03-3541-4141

Disclaimer

Yamato Holdings Co. Ltd. published this content on 23 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 December 2021 06:06:02 UTC.


© Publicnow 2021
All news about YAMATO HOLDINGS CO LTD
05/03SLAMcore Limited announced that it has received $16 million in funding from a group of ..
CI
04/12CYCLOTECH AND YAMATO REVEAL INNOVATI : 456.4kb]
PU
04/01Australian Shares Post Small Loss Amid Decline in Business Confidence
MT
03/30YAMATO HOLDINGS CO., LTD. : Ex-dividend day for final dividend
FA
03/23YAMATO : Integrated Report 2021(A3)
PU
03/22YAMATO : Corporate Governance Report
PU
03/15CONSOLIDATED STATEMENT OF COMPREHENS : 38.4kb]
PU
03/15CONSOLIDATED STATEMENT OF CHANGES IN : 42kb]
PU
03/15CONSOLIDATED STATEMENT OF CASH FLOWS : 40.6kb]
PU
03/15NOTES TO CONSOLIDATED FINANCIAL STAT : 167kb]
PU
More news
Analyst Recommendations on YAMATO HOLDINGS CO LTD
More recommendations
Financials
Sales 2022 1 789 B 13 995 M 13 995 M
Net income 2022 49 696 M 389 M 389 M
Net cash 2022 161 B 1 260 M 1 260 M
P/E ratio 2022 16,6x
Yield 2022 1,99%
Capitalization 844 B 6 599 M 6 599 M
EV / Sales 2022 0,38x
EV / Sales 2023 0,38x
Nbr of Employees 220 000
Free-Float 81,9%
Chart YAMATO HOLDINGS CO LTD
Duration : Period :
Yamato Holdings Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends YAMATO HOLDINGS CO LTD
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 2 310,00 JPY
Average target price 2 749,09 JPY
Spread / Average Target 19,0%
EPS Revisions
Managers and Directors
Yutaka Nagao Manager-Yamaguchi Branch
Kenichi Shibasaki Manager-Saitama Regional Branch
Masaki Yamauchi Executive Officer & Head-Personnel Strategy
Toshitaka Hagiwara Independent Outside Director
Masakatsu Mori Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
YAMATO HOLDINGS CO LTD-14.54%6 579
UNITED PARCEL SERVICE INC-20.20%149 449
FEDEX CORPORATION-22.32%52 069
DEUTSCHE POST AG-33.75%48 212
EXPEDITORS INTERNATIONAL OF WASHINGTON INC.-21.48%17 688
SG HOLDINGS CO.,LTD.-15.08%11 363